Citations

Clear

3942 citation(s) found for "To, Van".

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, Karoline , McGuffog, Lesley , Barrowdale, Daniel , Lee, Andrew , Soucy, Penny, Ramus, Susan J. , Terry, Mary Beth , Schmutzler, Rita K., Simard, Jacques , Pharoah, Paul D.P., Offit, Kenneth, Chenevix‐Trench, Georgia , Easton, Douglas F. , Antoniou, Antonis C, Nathanson, Katherine L. , Radice, Paolo , Jakubowska, Anna , Lubiński, Jan , Engel, Christoph , Durocher, Francine , Weitzel, Jeffrey N. , Olopade, Olufunmilayo I. , John, Esther M. , Southey, Melissa C. , Eeles, Rosalind A. , Benı́tez, Javier , Ganz, Patricia A. , Gómez, E. , Peterlongo, Paolo , Pensotti, Valeria , Giannini, Giuseppe , Jensen, Uffe Birk , Caligo, Maria A. , Ehrencrona, Hans , Adlard, Julian , Eccles, Diana , Mazoyer, Sylvie , Montagna, Marco , Teo, Soo‐Hwang , Rensburg, Elizabeth J. van , Dı́ez, Orland , Hoya, Miguel de la , Mulligan, Anna Marie , Konstantopoulou, Irene , Vijai, Joseph , Brunet, Joan , Kwong, Ava , James, Paul A. , Claes, Kathleen , Doorn, Helena C. van , Teixeira, Manuel R. , Rennert, Gad , Hulick, Peter J. , Lesueur, Fabienne , Azzollini, Jacopo , Hauke, Jan , Teulé, Àlex , Dennis, Joe , Domchek, Susan M. , Robson, Mark E. , Spurdle, Amanda B. , Mavaddat, Nasim , Neuhausen, Susan L. , Couch, Fergus J. , Antoniou, Antonis C. , Caligo, Maria A , Hulick, Peter J , James, Paul , Lesueur, Fabienne , Peterlongo, Paolo , Ramus, Susan J , Rennert, Gad , Teixeira, Manuel R , Teo, Soo H , van Rensburg, Elizabeth J , Eccles, Diana , de la Hoya, Miguel , Diez, Orland , Radice, Paolo , Weitzel, Jeffrey N , Claes, Kathleen B M , Adlard, Julian , Azzollini, Jacopo , Brunet, Joan , Eeles, Rosalind A , Ehrencrona, Hans , John, Esther M , Joseph, Vijai , Konstantopoulou, Irene , Olopade, Olufunmilayo I , Southey, Melissa C , Jakubowska, Anna , Nathanson, Katherine L , Barrowdale, Daniel , Benitez, Javier , Engel, Christoph , Montagna, Marco , Simard, Jacques , Chenevix-Trench, Georgia , Gómez-García, Encarna B , Hauke, Jan , Lubinski, Jan , Terry, Mary Beth , Kwong, Ava

Mayo Clinic

JNCI: Journal of the National Cancer Institute | November 29, 2016 | Volume: 109 | Issue: 7 | Pages: No page available

10.1093/jnci/djw302 | PMID 28376175 Get It

Aneuploidy in Cancer and Aging
Naylor, Ryan M. , Deursen, Jan M. van

Mayo Clinic

Annual Review of Genetics | November 28, 2016 | Volume: 50 | Issue: 1 | Pages: 45-66

10.1146/annurev-genet-120215-035303 | PMID 27893964 Get It

Chromosomal instability (CIN), the persistent inability of a cell to faithfully segregate its genome, is a feature of many cancer cells. It stands to reason that CIN enables the acquisition of multiple cancer hallmarks; however, there is a growing body of evidence suggesting that CIN impairs cellular fitness and prevents neoplastic transformation. Here, we suggest a new perspective to reconcile this apparent paradox and share an unexpected link between aneuploidy and aging that was discovered through attempts to investigate the CIN-cancer relationship. Additionally, we provide a comprehensive overview of the function and regulation of the anaphase-promoting complex, an E3 ubiquitin ligase that mediates high-fidelity chromosome segregation, and describe the mechanisms that lead to whole-chromosome gain or loss. With this review, we aim to expand our understanding of the role of CIN in cancer and aging with the long-term objective of harnessing this information for the advancement of patient care.
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
Hamdi, Yosr , Collaborators, NBCS, Soucy, Penny, Adoue, Véronique , Michailidou, Kyriaki , Canisius, Sander , Lemaçon, Audrey , Droit, Arnaud , Andrulis, Irene L. , Baynes, Caroline, Blomqvist, Carl , Bogdanova, Natalia , Bojesen, Stig E. , Bolla, Manjeet K. , Børresen‐Dale, Anne‐Lise , Brand, Judith S. , Brauch, Hiltrud , Brenner, Hermann , Burwinkel, Barbara , Chang‐Claude, Jenny , Darabi, Hatef, Devilee, Peter , Dörk, Thilo , Eriksson, Mikael , Fasching, Peter A. , Figueroa, Jonine D. , Flyger, Henrik, García‐Closas, Montserrat , Goldberg, Mark S. , González‐Neira, Anna , Grenaker-Alnæs, Grethe Irene, Guénel, Pascal , Haeberle, Lothar, Haiman, Christopher A., Hamann, Ute, Hallberg, Emily, Hooning, Maartje J. , Jakubowska, Anna , Jones, Michael E. , Kabisch, Maria, Kataja, Vesa , Lambrechts, Diether , Lindblom, Annika , Lubiński, Jan , Mannermaa, Arto, Maranian, Mel, Margolin, Sara , Marme, Frederik, Neven, Patrick , Olswold, Curtis, Peto, Julian, Plaseska‐Karanfilska, Dijana , Pylkäs, Katri , Radice, Paolo , Sawyer, Elinor J. , Schmidt, Marjanka K. , Shu, Xiao-Ou , Southey, Melissa C. , Swerdlow, Anthony J. , Tollenaar, Rob A.�E.�M. , Tomlinson, Ian , Torres, Diana , Truong, Thérèse , Vachon, Celine M. , Ouweland, Ans M.W. van den, Wang, Qin , Winqvist, Robert , Investigators, kConFab AOCS, Benı́tez, Javier , Chenevix‐Trench, Georgia , Dunning, Alison M. , Kristensen, Vessela N. , Easton, Douglas F. , Pastinen, Tomi , Simard, Jacques , Durocher, Francine , Zheng, Wei , Thorne, Heather , Lambrechts, Diether , Vachon, Celine, Collaborators, NBCS, Anton‐Culver, Hoda , Arndt, Volker , Bonanni, Bernardo , Broeks, Annegien , Couch, Fergus J. , Cox, Angela , Cross, Simon S. , Czene, Kamila , Dennis, Joe , dos‐Santos‐Silva, Isabel , Eriksson, Mikael , Giles, Graham G. , Hooning, Maartje J. , Hopper, John L. , Marchand, Loı̈c Le , Mannermaa, Arto , Milne, Roger L. , Neuhausen, Susan L. , Nevanlinna, Heli , Rudolph, Anja , Vachon, Celine M. , Zheng, Wei , Pharoah, Paul D.P. , Hall, Per N , Nord, Silje , Dörk, Thilo , Lambrechts, Diether , Swerdlow, Anthony J , Radice, Paolo , Southey, Melissa C , Dunning, Alison M , Jakubowska, Anna , Jones, Michael E , Lambrechts, Diether , Brenner, Hermann , Guénel, Pascal , Torres, Diana , García-Closas, Montserrat , Schmidt, Marjanka K , Michailidou, Kyriaki , Bogdanova, Natalia V , Benitez, Javier , Simard, Jacques , Chenevix-Trench, Georgia , Zheng, Wei , Figueroa, Jonine D , Pylkäs, Katri , Devilee, Peter , Lubinski, Jan , Bojesen, Stig E , Truong, Therese , Brauch, Hiltrud , Lindblom, Annika , Plaseska-Karanfilska, Dijana , Sawyer, Elinor J , Droit, Arnaud

Mayo Clinic

Oncotarget | November 28, 2016 | Volume: 7 | Issue: 49 | Pages: 80140-80163

10.18632/oncotarget.12818 | PMID 27792995 Get It

Profile of cognitive impairment and underlying pathology in multiple system atrophy
Koga, Shunsuke , Parks, Adam , Uitti, Ryan J. , Gerpen, Jay A. van, Cheshire, William P. , Van Gerpen, Jay A, Wszołek, Zbigniew K. , Dickson, Dennis W. , Koga, Shunsuke , Cheshire, William P

Mayo Clinic

Movement Disorders | November 16, 2016 | Volume: 32 | Issue: 3 | Pages: 405-413

10.1002/mds.26874 | PMID 27859650 Get It

ABSTRACTBackgroundThe objectives of this study were to elucidate any potential association between α‐synuclein pathology and cognitive impairment and to determine the profile of cognitive impairment in multiple system atrophy (MSA) patients. To do this, we analyzed the clinical and pathologic features in autopsy‐confirmed MSA patients.MethodsWe retrospectively reviewed medical records, including neuropsychological test data, in 102 patients with autopsy‐confirmed MSA in the Mayo Clinic brain bank. The burden of glial cytoplasmic inclusions and neuronal cytoplasmic inclusions were semiquantitatively scored in the limbic regions and middle frontal gyrus. We also assessed concurrent pathologies potentially causing dementia including Alzheimer's disease, hippocampal sclerosis, and cerebrovascular pathology.ResultsOf 102 patients, 33 (32%) were documented to have cognitive impairment. Those that received objective testing, deficits primarily in processing speed and attention/executive functions were identified, which suggests a frontal‐subcortical pattern of dysfunction. Of these 33 patients with cognitive impairment, 8 patients had concurrent pathologies of dementia. MSA patients with cognitive impairment had a greater burden of neuronal cytoplasmic inclusions in the dentate gyrus than patients without cognitive impairment, both including and excluding patients with concurrent pathologies of dementia.ConclusionsThe cognitive deficits observed in this study were more evident on neuropsychological assessment than with cognitive screens. Based on these findings, we recommend that clinicians consider more in‐depth neuropsychological assessments if patients with MSA present with cognitive complaints. Although we did not identify the correlation between cognitive deficits and responsible neuroanatomical regions, a greater burden of neuronal cytoplasmic inclusions in the limbic regions was associated with cognitive impairment in MSA. © 2016 International Parkinson and Movement Disorder Society
Magnetic resonance elastography (MRE) of the human brain: technique, findings and clinical applications
Hiscox, Lucy V. , McGarry, Matt D J, Starr, John M. , Roberts, Neil , Johnson, Curtis L. , Barnhill, Eric , McGarry, Matthew D. J. , Huston, John , Beek, Edwin J.R. van

Mayo Clinic

Physics in Medicine & Biology | November 15, 2016 | Volume: 61 | Issue: 24 | Pages: R401-R437

10.1088/0031-9155/61/24/r401 | PMID 27845941 Get It

Abstract Neurological disorders are one of the most important public health concerns in developed countries. Established brain imaging techniques such as magnetic resonance imaging (MRI) and x-ray computerised tomography (CT) have been essential in the identification and diagnosis of a wide range of disorders, although usually are insufficient in sensitivity for detecting subtle pathological alterations to the brain prior to the onset of clinical symptoms—at a time when prognosis for treatment is more favourable. The mechanical properties of biological tissue provide information related to the strength and integrity of the cellular microstructure. In recent years, mechanical properties of the brain have been visualised and measured non-invasively with magnetic resonance elastography (MRE), a particularly sensitive medical imaging technique that may increase the potential for early diagnosis. This review begins with an introduction to the various methods used for the acquisition and analysis of MRE data. A systematic literature search is then conducted to identify studies that have specifically utilised MRE to investigate the human brain. Through the conversion of MRE-derived measurements to shear stiffness (kPa) and, where possible, the loss tangent (rad), a summary of results for global brain tissue and grey and white matter across studies is provided for healthy participants, as potential baseline values to be used in future clinical investigations. In addition, the extent to which MRE has revealed significant alterations to the brain in patients with neurological disorders is assessed and discussed in terms of known pathophysiology. The review concludes by predicting the trends for future MRE research and applications in neuroscience.
Histone H4 Methyltransferase Suv420h2 Maintains Fidelity of Osteoblast Differentiation
Khani, Farzaneh , Thaler, Roman , Paradise, Christopher R. , Deyle, David R. , Julio, Marianne Kruijthof‐de, Galindo, Mario , Gordon, Jonathan A. R., Dudakovic, Amel , Wijnen, André J. van , van Wijnen, Andre J, Stein, Gary S. , van Wijnen, Andre J , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Biochemistry | November 10, 2016 | Volume: 118 | Issue: 5 | Pages: 1262-1272

10.1002/jcb.25787 | PMID 27862226 Get It

ABSTRACTOsteogenic lineage commitment and progression is controlled by multiple signaling pathways (e.g., WNT, BMP, FGF) that converge on bone‐related transcription factors. Access of osteogenic transcription factors to chromatin is controlled by epigenetic regulators that generate post‐translational modifications of histones (“histone code”), as well as read, edit and/or erase these modifications. Our understanding of the biological role of epigenetic regulators in osteoblast differentiation remains limited. Therefore, we performed next‐generation RNA sequencing (RNA‐seq) and established which chromatin‐related proteins are robustly expressed in mouse bone tissues (e.g., fracture callus, calvarial bone). These studies also revealed that cells with increased osteogenic potential have higher levels of the H4K20 methyl transferase Suv420h2 compared to other methyl transferases (e.g., Suv39h1, Suv39h2, Suv420h1, Ezh1, Ezh2). We find that all six epigenetic regulators are transiently expressed at different stages of osteoblast differentiation in culture, with maximal mRNAs levels of Suv39h1 and Suv39h2 (at day 3) preceding maximal expression of Suv420h1 and Suv420h2 (at day 7) and developmental stages that reflect, respectively, early and later collagen matrix deposition. Loss of function analysis of Suv420h2 by siRNA depletion shows loss of H4K20 methylation and decreased expression of bone biomarkers (e.g., alkaline phosphatase/Alpl) and osteogenic transcription factors (e.g., Sp7/Osterix). Furthermore, Suv420h2 is required for matrix mineralization during osteoblast differentiation. We conclude that Suv420h2 controls the H4K20 methylome of osteoblasts and is critical for normal progression of osteoblastogenesis. J. Cell. Biochem. 118: 1262–1272, 2017. © 2016 Wiley Periodicals, Inc.
Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients
Asante, Dennis, Houten, Holly Van, Sangaralingham, Lindsey R. , Herrmann, Joerg , Reneau, John C, Van Houten, Holly, Buadi, Francis K. , Reneau, John C. , Lerman, Amir

Mayo Clinic

American Journal of Hematology | November 4, 2016 | Volume: 92 | Issue: 2 | Pages: No page available

10.1002/ajh.24599 | PMID 27813147 Get It

Senescent intimal foam cells are deleterious at all stages of atherosclerosis
Childs, Bennett G. , Baker, Darren J. , Wijshake, Tobias , Conover, Cheryl A. , Campisi, Judith , Deursen, Jan M. van , Baker, Darren J

Mayo Clinic

Science | October 27, 2016 | Volume: 354 | Issue: 6311 | Pages: 472-477

10.1126/science.aaf6659 | PMID 27789842 Get It

Wreaking havoc while (growth-)arrested Cells enter a state of senescence in response to certain stresses. Studying mouse models, Childs et al. examined the role of senescent lipid-loaded macrophages (so-called “foam cells”) in the pathogenesis of atherosclerosis. At early stages of atherosclerosis, senescent foam cells promoted the expression of inflammatory cytokines. At later stages, they promoted the expression of matrix metalloproteases implicated in the rupture of atherosclerotic plaque, which can lead to blood clots. Experimental removal of the senescent cells had beneficial effects at both stages of the disease. Science , this issue p. 472
Safety Studies for Use of Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells in a Rabbit Model for Osteoarthritis to Support a Phase I Clinical Trial
Riester, Scott M. , Denbeigh, Janet M. , Yang, Lin , Jones, Dakota L. , Mooij, Tristan de, Lewallen, Eric A. , Nie, Hai , Paradise, Christopher R. , Radel, Darcie J., Dudakovic, Amel , Camilleri, Emily T. , Qu, Wenchun , Krych, Aaron J. , Frick, Matthew A., Im, Hee‐Jeong , Dietz, Allan B. , Smith, Jay , Wijnen, André J. van , Camilleri, Emily , Lin, Yang , de Mooij, Tristan, Larson, Dirk R. , van Wijnen, Andre J, van Wijnen, Andre J , Krych, Aaron J , Dietz, Allan B , van Wijnen, Andre J , Camilleri, Emily

Mayo Clinic

Stem Cells Translational Medicine | October 27, 2016 | Volume: 6 | Issue: 3 | Pages: 910-922

10.5966/sctm.2016-0097 | PMID 28297568 Get It

AbstractAdipose-derived mesenchymal stem cells (AMSCs) offer potential as a therapeutic option for clinical applications in musculoskeletal regenerative medicine because of their immunomodulatory functions and capacity for trilineage differentiation. In preparation for a phase I clinical trial using AMSCs to treat patients with osteoarthritis, we carried out preclinical studies to assess the safety of human AMSCs within the intra-articular joint space. Culture-expanded human AMSCs grown in human platelet-lysate were delivered via intra-articular injections into normal healthy rabbit knees and knees at risk for the development of osteoarthritis after bilateral medial anterior hemimeniscectomy. Treatment outcomes and safety were evaluated by assessing the general health, function, and behavior of the animals. Joint tissues were analyzed by x-ray, magnetic resonance imaging, and histopathology. Intra-articular AMSC therapy was well tolerated in this study. We did not observe adverse systemic reactions, nor did we find evidence of damage to intra-articular joint tissues. Thus, the data generated in this study show a favorable safety profile for AMSCs within the joint space in support of a phase I clinical trial evaluating the clinical utility of AMSCs to treat osteoarthritis.
Variability Of Biomarkers in Patients with Chronic Heart Failure and Healthy Controls
Meijers, Wouter C. , Velde, A. Rogier van der , Kobold, Anneke C. Muller , Dijck‐Brouwer, D.A. Janneke , Wu, Alan H.B. , Jaffe, Allan S. , Boer, Rudolf A. de , Jaffe, Allan, Jaffe, Allan S. , de Boer, Rudolf A

Mayo Clinic

European Journal of Heart Failure | October 21, 2016 | Volume: 19 | Issue: 3 | Pages: 357-365

10.1002/ejhf.669 | PMID 27766733 Get It

Abstract Aims Biomarkers can be used for diagnosis, risk stratification, or management of patients with heart failure (HF). Knowledge about the biological variation is needed for proper interpretation of serial measurements. Therefore, we aimed to determine and compare the biological variation of a large panel of biomarkers in healthy subjects and in patients with chronic HF. Methods and results The biological variability of established biomarkers [NT-proBNP and high-sensitivity troponin T (hsTnT)], novel biomarkers [galectin-3, suppression of tumorigenicity 2 (ST2), and growth differentiation factor 15 (GDF-15)], and renal/neurohormonal biomarkers (aldosterone, phosphate, parathyroid hormone, plasma renin concentration, and creatinine) was determined in 28 healthy subjects and 83 HF patients, over a period of 4 months and 6 weeks, respectively. The analytical (CVa), intraindividual (CVi), and interindividual (CVg) variations were calculated, as well as the reference change value (RCV), which reflects the percentage of change that may indicate a ‘relevant’ change. All crude biomarker levels were significantly increased or decreased in HF patients compared with controls (all P < 0.01). Variation indices were comparable in healthy individuals and HF patients. CVi was not influenced by the individual levels of the biomarker itself. NT-proBNP and GDF-15 had relatively high CVi (21.8% and 16.6%) and RCV (61.7% and 64.3%), whereas ST2 (CVi, 15.0; RCV, 42.9%), hsTnT (CVi, 11.1; RCV, 31.4%), and galectin-3 (CVi, 8.1; RCV, 25.0%) had lower indices of variation. Conclusion Biological variation indices are comparable between healthy subjects and HF patients for a broad spectrum of biomarkers. NT-proBNP and GDF-15 have substantial variation, with lower variation for ST2, hsTnT, and galectin-3. These data are instrumental in proper interpretation of biomarker levels in HF patients.